3 Stocks Selling at a 33% Discount

Pfizer (PFE) shares have gained 20% since the company announced in January 2009 that it would buy rival Wyeth for $68 billion. That rally sounds like validation of the deal--until it's compared with the S&P 500's gain of 63% during the same period....